Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK + (Immuno ALCL)

Gustave Roussy

Status: Completed

Conditions: ALCL

Treatments: Other: Blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT02902874

2009-A01343-54

2009/1603 (Other Identifier)

Details and patient eligibility

About

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Enrollment: 185 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Every patients treated according to COPAD-IGR, HM 89,91 and 97 and ALCL99 protocols and included in related studies
• Clinical data registered in SFCE database
• Signed consent form

Exclusion criteria

• No ALK expression on tumour
• No consent signed

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

185 participants in 1 patient group

Patients treated for anaplastic large cell lymphoma ( ALCL )

Experimental group

Treatment:

Other: Blood sample